Emtricitabine Recruiting Phase 4 Trials for Drug Use / Human Immunodeficiency Virus Type 1 (HIV-1) Infection Other

IndicationsStatusPurposePhase
RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT04132674Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed